-
Study aim
-
Determine of the effect of dry Cupping Therapy on fatigue and quality of life in patients with Multiple Sclerosis
-
Design
-
This study is a clinical trial with two groups (intervention and control), single blinded (the data analyst) and randomized, with 30 patients in each group.
-
Settings and conduct
-
This single blinded study (the data analyst), will be done in the Kerman Medical Center of the Special Diseases.
In the intervention group, 8 sessions of dry Cupping Therapy will be performed. The variables will be measured before and after the intervention.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Ability to communicate in Persian language, diagnosis of Multiple Sclerosis according to neurologist confirmation, the severity of mental fatigue at the beginning of the research on the Fatigue Severity Scale (FSS) is equal to or greater than thirty six, the absence of chronic diseases and other conditions that affect the fatigue and quality of life of people, such as diabetes, cancer, etc, Not having surgery for the last six months, abnormal wound and redness from the scapula to the waist.
Exclusion criteria: Use of anticoagulants, coagulopathy, getting severe psychological disorders that are inappropriate for participation in this study, a change in the course of the disease that causes the patient to be hospitalized, failure to follow the Dry Cupping Therapy program by the patient for any reason and some cases of recurrence of symptoms during the intervention so that it can affect our intervention.
-
Intervention groups
-
In the intervention group, 8 sessions of Dry Cupping Therapy will be performed in 4 weeks and two sessions per week, While patients in the control group will receive routine fatigue reduction methods. The severity of fatigue and the quality of life score will be measured before and after the intervention.
-
Main outcome variables
-
fatigue and quality of life